蛋白酶激活受体2:瘤的跳板
David Vetvicka1, Petr Suhaj2, Tomas Olejar2
1Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic; david.vetvicka@lf1.cuni.cz.
Anticancer research
|December 30, 2023
概括
蛋白酶激活受体-2 (PAR-2) 在癌症进展和宿主免疫力中起着关键作用. 这篇评论探讨了PAR-2的情况.
科学领域:
- 瘤学和免疫学
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 蛋白酶激活受体 (PAR) 已经研究了25多年,重点是它们在癌细胞代谢,信号传递和增殖中的作用.
- 对宿主反应中PAR的研究主要集中在血栓受体 (PAR-1, PAR-3, PAR-4) 和它们与血液凝结和转移的联系上.
- 帕尔-2在抗瘤免疫中的特定作用及其在癌症发展中的更广泛功能仍未得到充分研究.
研究的目的:
- 审查当前对癌症中蛋白酶激活受体-2 (PAR-2) 的理解.
- 阐明PAR-2在癌症发育和进展过程中对癌细胞和免疫细胞的功能.
- 讨论PAR-2激活对癌症相关疼痛的影响.
主要方法:
- 对癌症中PAR-2现有研究的文献综述.
- 对研究PAR-2表达和功能在各种细胞类型上的研究进行分析.
- 关于PAR-2参与抗瘤免疫和癌症进展的综合数据.
主要成果:
- PAR-2涉及癌细胞自主功能和宿主免疫反应.
- PAR-2的激活会影响癌症的发展,进展和转移.
- 新出现的证据将PAR-2与癌症相关的疼痛联系在一起,这表明它具有多方面的作用.
结论:
- 在癌症生物学和宿主免疫力中,PAR-2 是一个重要的,但尚未被充分研究的因素.
- 对PAR-2的机制进行进一步的研究对于了解癌症进展和开发新的治疗策略至关重要.
- 准PAR-2可能为癌症治疗和疼痛管理提供新的途径.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:26Receptor Tyrosine Kinases
13.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K